Rosen Law Firm has filed a class action lawsuit on behalf of investors who bought Everest Group stock between February 2024 and October 2025. The lawsuit alleges that Everest made false and misleading statements about its exposure to casualty risks, underpriced business segments, and insufficient reserves, which overstated earnings. Investors may be entitled to compensation if they join the lawsuit before December 28, 2026. The case is ongoing, and no class has yet been certified.
The Everest Group securities fraud lawsuit presents a legal development for investors. For readers following the Financials sector, here is Pluang's market snapshot as of Oct 29, 2026 23:51 WIB: out of 142 priced US Financials stocks, 115 rose and 27 fell today. Notable movers include SEZL (Sezzle Inc) at USD 134.47 with a 1-day change of +3.43% and a typical hold time of 16 days, RKT (Rocket Companies Inc. Class A) at USD 11.96 with +3.41% change and a typical hold time of 2 days, and CG (Carlyle Group Inc) at USD 40.22 with +2.96% change, 0% sell and 100% buy order activity, and a typical hold time of 112 days.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
